Recruiting

HS-1000

Sponsor:

HeadSense Medical

Code:

NCT02699346

Conditions

Brain Concussion

Brain Injuries

Eligibility Criteria

Sex: All

Age: 13 - 25

Healthy Volunteers: Accepted

Interventions

HS-1000 recording

Study Details

Brief summary:

The HeadSense (HS) HS-1000 device, a new non-invasive brain monitor is expected to safely and accurately monitor concussed patients with minimal discomfort, potentially providing a new modality for concussion measurement. The device is based on advanced signal analysis algorithms that analyze a very low frequency acoustic signal (within the audible range) generated by the device. The acoustic signal is transmitted using a small transmitter, placed in the participant's ear, and picked by an acoustic sensor placed in the other ear.

Conditions

Brain Concussion

Brain Injuries

Study ID

NCT02699346

Start date

Jan, 2015

Status verified date

Dec, 2016

Completion date

Mar, 2018

Anticipated

Primary completion date

Jun, 2017

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 13 - 25

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Healthy subjects with no previous concussions:

1. Male or female subjects, aged 13 - 25 years old at screening visit
2. Subjects who were previously diagnosed by standard methods as healthy subjects with no previous concussions
3. Subject is able and willing to comply with the requirements of the protocol
4. Subject is able to understand and sign written informed consent to participate in the study
  • Post-concussion diagnosed patients:

1. Male or female subjects, aged 13-25 years at screening visit
2. Subjects who were previously diagnosed by standard methods as suffering from concussion
3. Subject is able and willing to comply with the requirements of the protocol
4. Subject is able to understand and sign written informed consent to participate in the study

Exclusion Criteria:

1. Local ear infection
2. Known allergy or hypersensitivity to any of the test materials or contraindication to test materials
3. Subjects currently enrolled in or less than 30 days post-participation in other investigational device or drug study(s), or receiving other investigational agent(s)
4. Any condition that may jeopardize study participation (e.g., abnormal clinical or laboratory finding) or interpretation of study results, or may impede the ability to obtain informed consent
5. History of psychiatric illness, chemical dependency, Attention-Deficit Hyperactivity Disorder (ADHD), Learning Disability, seizure disorder, prior neurosurgical intervention
6. Current use of psychotropic medication

Study Design

Enrollment

100 participants

Anticipated

Intervention Model

Single group

Primary purpose

Diagnostic

Interventions and Outcome Measures

Arms

experimental: HS-1000 recording

Eligible patients and healthy subjects will be enrolled into the study and HS-1000 headset portion of the device will be placed in their ears. HS-1000 monitoring intervals will last from 20 minutes continuously. Following completion of data collection, HS-1000 will be removed.

Interventions

HS-1000 recording

Primary outcome measure

  • To measure ICP values by using the HS-1000 in healthy subjects and concussed subjects [ Time Frame: 20 minute recording session ]
  • Determine the correlation between ICP measurements obtained from the HS-1000 device and the clinical findings from the modified Balance Error Score System (mBESS) and ImPACT scores in post-concussion patients. [ Time Frame: 20 minute recording session ]

Central Contacts and Locations

Central contacts

Locations

Vanderbilt University Medical Center

Recruiting

Nashville, Tennessee, United States, 37232

Contacts

Principal Investigator:

Allen K Sills, MD

More Information

Sponsor

HeadSense Medical

Last update posted

Dec 22, 2016

Last verified

Dec, 2016

Keywords

  • concussion
  • mild traumatic brain injuries

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by HeadSense Medical on 2016-12-22.